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Allele-specific repression of Sox2 
through the long non-coding RNA 
Sox2ot
Tobias C. Messemaker1,2, Selina M. van Leeuwen1, Patrick R. van den Berg  3, Anke E. J. ‘t 
Jong  1, Robert-Jan Palstra4, Rob C. Hoeben1, Stefan Semrau3 & Harald M. M. Mikkers1
The transcription factor Sox2 controls the fate of pluripotent stem cells and neural stem cells. This 
gatekeeper function requires well-regulated Sox2 levels. We postulated that Sox2 regulation is 
partially controlled by the Sox2 overlapping long non-coding RNA (lncRNA) gene Sox2ot. Here we 
show that the RNA levels of Sox2ot and Sox2 are inversely correlated during neural differentiation of 
mouse embryonic stem cells (ESCs). Through allele-specific enhanced transcription of Sox2ot in mouse 
Sox2eGFP knockin ESCs we demonstrate that increased Sox2ot transcriptional activity reduces Sox2 
RNA levels in an allele-specific manner. Enhanced Sox2ot transcription, yielding lower Sox2 RNA levels, 
correlates with a decreased chromatin interaction of the upstream regulatory sequence of Sox2 and 
the ESC-specific Sox2 super enhancer. Our study indicates that, in addition to previously reported 
in trans mechanisms, Sox2ot can regulate Sox2 by an allele-specific mechanism, in particular during 
development.
Correct gene regulation, which relies on the temporally and spatially controlled expression of lineage specific 
transcription factors, determines the success of development. Sox2 is such a transcription factor key to develop-
ment. Sox2 belongs to the family of high mobility group (HMG) DNA binding domain genes related to the sex 
determining gene Y (Sry) and together with Sox1 and Sox3, Sox2 forms the SoxB1 family. Sox2 exerts its cell type 
specific function by interaction with other homeodomain transcription factors, the POU domain protein Oct4, or 
the paired domain protein Pax61. An important function of Sox2 is maintaining the stem cell state of either naïve 
or primed pluripotent stem cells2. Reduction or overexpression of Sox2 in mouse and human embryonic stem 
cells (ESCs) induces the differentiation into primarily endoderm and trophoectoderm-like cells, respectively3–8. 
Endogenous Sox2 levels also influence the germ layer fate of pluripotent stem cells. High endogenous levels steer 
pluripotent cells into the (neural) ectodermal lineage, whereas low levels promote mesendodermal differentia-
tion9. Sox2 fulfills a similar role in neural stem cells (NSCs) in vitro and in vivo. Overexpression of Sox2 in NSCs 
of the developing spinal cord represses differentiation by counteracting transcription factor driven proneural 
programs, whereas Sox2 protein inhibition enhances differentiation10,11. In the developing eye, retinal progenitor 
cells lose their proliferation and differentiation capacity after Sox2 ablation12. Reduced Sox2 levels (<40%) cause 
microphthalmia due to aberrant differentiation of the progenitor cells12. In addition, misexpression of Sox2 in 
astrocytes converts them into neuroblasts13, whereas it activates neural transcription programs in cells of mes-
odermal origin14,15. Thus, well-controlled and tightly-timed Sox2 activity appears to be important for correct 
neural development.
Sox2 activity is controlled by post-translational modifications, such as serine- and threonine phosphoryla-
tion, sumoylation, ubiquitination, and acytelation16. These modifications affect localization, DNA binding and 
stability. However, Sox2 activity is to a great extent controlled at the transcriptional level. The requirement for 
well-balanced, tightly controlled, and cell type specific expression explains the complex genomic architecture 
of the Sox2 locus. Multiple enhancer elements that drive tissue specific expression have been identified in the 
200 kb region surrounding Sox217–20. Consequently, endogenous expression has only been fully recapitulated in 
transgenic mice through a knockin approach where one of the Sox2 alleles was replaced by a marker gene12,21,22 
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or through introduction of bacterial artificial chromosomes (BACs) containing >200 kb of Sox2 genomic 
sequences23.
Protein encoding genes like transcription factors and chromatin modifiers are key to transcription activa-
tion. However, RNA genes that do not encode proteins can fulfill transcriptional regulatory roles as well. Long 
non-coding RNAs (lncRNAs), which are >200 nucleotides in length, seem to have in particular evolved for con-
trolling genes at a transcriptional level24. LncRNA-mediated transcription regulation is instructed in cis or in 
trans. Allele-specific in cis mechanisms include recruitment of chromatin modifying complexes repressing tran-
scription25 or activating transcription26, transcriptional interference preventing transcription factor access27,28, 
or gene looping29. Recently, a lncRNA gene called Sox2 overlapping transcript (Sox2ot) that is transcribed in 
the same direction as Sox2 and is polyadenylated downstream of Sox2 was described30,31. To date several studies 
investigating the function of Sox2ot have been reported32–34. These studies utilized knockdown or overexpression 
of Sox2ot in cancer cell lines and the results have indicated a role of Sox2ot in regulating proliferation as well as 
regulating Sox2. Sox2ot levels were invariably positively correlated with Sox2, however, the underlying regulatory 
mechanism has remained unknown.
In this study we evaluated expression of Sox2ot during development and studied the effect of Sox2ot overex-
pression in modified mouse ESCs that allow discrimination between cis and trans regulatory effects. On basis of 
our data we propose that during development Sox2ot expression is mainly restricted to neural cell types and that, 
in contrast to previous reports, enhanced Sox2ot transcriptional activity negatively affects Sox2 RNA levels in an 
allele-specific manner.
Results
Characterization and conservation of Sox2ot transcripts. The Sox2 gene is a single exon gene that 
is located in a gene desert on mouse chromsosome 3 (Fig. 1a). Apart from Sox2 the only genes located within a 
200 kb stretch of genomic DNA are presumably of non-coding nature. Two lncRNA genes (Sox2otb and Sox2otc) 
have been identified in this region31. The transcripts are initiated (~88 kb and ~11 kb) upstream of Sox2 and are 
terminated ~40 kb downstream of Sox2 (Fig. 1a). Transcriptome data, such as ESTs (expressed sequence tags) rep-
resenting either Sox2ot transcript, have indicated that Sox2ot transcripts, like the flanking Sox2 gene, are predom-
inantly present in brain as well as cell lines of neural origin. The expression pattern points to a function of Sox2ot 
in neural development and neural physiology, possibly through a Sox2-related mechanism. We first validated the 
transcription Sox2ot genes in neural progenitor cells (NPCs) derived from the lateral wall of the lateral ventricle 
in adult mouse. Primers recognizing an exon of Sox2otb that also is the first exon of Sox2otc could amplify Sox2ot 
transcripts in early passage neurospheres (data not shown and Fig. 1g), which is in agreement with two recent 
studies31,35. Using 5′ RLM-RACE we confirmed the 5′ ends of Sox2otb and Sox2otc (Supplementary Fig. S1a). Full-
length cDNA sequence analysis showed extensive splicing, which is arguably random as almost any possible exon 
conjunction was retrieved. The splicing is largely conserved in other mammals as was recently shown34. We iden-
tified one previously undescribed exon located between Sox2otb exon 2 and Sox2otc exon 1 (Fig. 1a). We analyzed 
the cDNA sequences for the presence of open reading frames (ORFs) through Coding Potential Calculator36, 
NCBI’s ORFfinder, and a translation initiation prediction program (ATGpr) but the outcome underscored the 
non-coding nature of all Sox2otb and Sox2otc splice variants (Supplementary Fig. S1d,e, and f). To test whether 
the transcripts can be translated into a polypeptide we performed in vitro transcription/translation assays using 
the largest, multi-exonic, Sox2otb and Sox2otc cDNA sequences, but we could not detect any Sox2ot polypeptides 
(Supplementary Fig. S1g). This result indicates that Sox2otb and Sox2otc are likely of non-coding nature as was 
suggested before30,31. However, our analyses do not fully exclude the generation of very small peptides with a 
function, which can be produced from presumed non-coding RNA transcripts37.
Sox2ot exonic and intronic sequences have been conserved between mammals and vertebrates (Supplementary 
Fig. S1c)31. The extent of conservation of genomic sequences between man and other vertebrates, like marsupials, 
is a measure of importance of these sequences for development. A larger evolutionary distance, i.e. between man 
and pufferfish (Fugu rubripes) diverging 450 million years ago, has been shown to be even more instrumental in 
uncovering coding as well as non-coding sequences crucial for proper development38. It was previously reported 
that the highest level of evolutionary conservation was observed in the promoter proximal regions of lncR-
NAs39–41. Likewise, the regions surrounding Sox2otb exon1 and Sox2otc exon 1, and not the exonic sequences, are 
highly conserved between man and Fugu. The high conservation of Sox2ot proximal promoter regions infers that 
Sox2ot sequences that govern transcription are more important during development than the transcript per se.
Expression of Sox2ot during neural development. Since previous studies have indicated that Sox2ot 
expression positively correlates with Sox2 RNA, we wished to test the correlative expression during neural devel-
opment. We restricted the expression analysis to Sox2otb, Sox2otc and Sox2 only. First we analyzed expression of 
Sox2otb, Sox2otb and Sox2otc (from here on referred to as Sox2otb/c because the riboprobe contains Sox2otc exon 
1 sequence, which is also present Sox2otb transcripts), and Sox2 in developing mouse embryos using RNA whole 
mount in situ hybridization (ISH). At 9.25 dpc Sox2 expression is mainly restricted to the neural tube, develop-
ing brain, nasal placodes, otic vesicles and optic vesicles (Fig. 1b, Supplementary Fig. S2a,b) (sense controls in 
Supplementary Fig. S2c). In contrast, a probe recognizing Sox2otb showed an expression pattern limited to the 
ventral part of the neural tube and optic vesicle, whereas a probe hybridizing to Sox2otb/c showed additional 
expression in the developing brain and otic vesicles (Fig. 1b). The spatial and temporal specific expression pat-
terns of Sox2otb and Sox2otc during neural development indicate that the independent Sox2ot transcripts may 
have different roles. Although it is difficult to robustly interpret co-localization data at the single cell level on basis 
of RNA ISH using independent single probe hybridizations, the ISH data show that Sox2otb, Sox2otc and Sox2 are 
co-localized in tissues during neural development. To further investigate Sox2otb, Sox2otc and Sox2 coexpression 
we analyzed Sox2otb/c and Sox2 expression during the differentiation of mouse ESCs into neuroectoderm. In the 
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tested feeder-independent and feeder-dependent wild type mouse ESC lines Sox2otb/c is very lowly expressed 
during maintenance. This is in sharp contrast with a previous study, which claimed abundant expression of Sox2ot 
in ESCs31. To further corroborate the low level of Sox2ot expression in ESCs we measured transcription of Sox2ot 
in mouse ESCs by single molecule FISH (smFISH) using a probe set lying in intron 2 of Sox2otb. smFISH has 
single molecule sensitivity42, yet, Sox2otb transcripts were very rare confirming the qRT-PCR results (Fig. 1d, 
positive control in Supplementary Fig. S2d). We observed a strong upregulation of Sox2otb/c upon neurectoder-
mal differentiation using embryoid bodies (Fig. 1e, and Supplementary Fig. S2e). Upregulation coincides with 
the presence of neural progenitor/stem cells (NP/SCs) as measured through induction of Sox1, which is a very 
early and specific marker of the neuroectoderm lineage43. Sox2ot induction is all trans retinoic acid (ATRA) 
independent as neuroectodermal differentiation using knockout replacement serum (KRS) that is devoid of any 
form of retinol yielded a similar induction of Sox2otb/c (Fig. 1e). In more defined monolayer-based differentia-
tion conditions Sox2otb/c was also induced upon neural differentiation (Supplementary Fig. S2d, and f), whereas 
BMP4-mediated differentiation towards mesendoderm failed to induce Sox2otb/c RNA levels (Supplementary 
Fig. S2g) indicating a primary role of Sox2ot in neural development. These results differ from the observations by 
Amaral et al., who have reported higher Sox2ot expression levels in mouse ESCs and enhanced Sox2ot transcrip-
tion upon mesodermal commitment31. The discrepancies may be caused by differences in the used maintenance 
Figure 1. Co-expression of Sox2otb/c and Sox2 during mouse neural development. (a) Schematic 
representation of the Sox2 locus on mouse chromosome 3 (mm9 assembly). Depicted are the single exon gene 
Sox2, and the overlapping Sox2otb and Soxtotc genes. Sox2otb shares exons 4, 5 and 6 with Sox2otc. *Indicates  a 
newly identified exon. (b) Whole mount RNA in situ hybridization of E9.25 mouse embryos using antisense 
Sox2, Sox2otbc and Sox2otb RNA probes. Scale bar represents 1 mm. otv, otic vesicle; opv, optic vesicle; nt, 
neural tube; bv, brain vesicle. (c) Transverse sections of the embryos depicted in b. Dashed line in b indicates 
the level of the transverse section. nt, neural tube. Scale bar represents 100 μm. (d) smFISH on mouse ESCs 
using Sox2otb intron 2 (upper panel) or Sox2 (lower panel) probe sets. Nuclei are stained with DAPI. (e) and (f) 
qRT-PCR analysis of Sox2otb/c and Sox1 (e), or Sox2otb/c and Sox2 (f) RNA levels during EB-mediated neural 
differentiation of mouse ESCs. Cells were cultured for 4 days in FBS or KSR containing medium followed by 
another 4 days in the same medium with 0.5 μM ATRA. (g) qRT-PCR analysis of Sox2otb/c and Sox2 RNA 
levels in mouse ESCs, ESC-derived radial glia-like NS cells and NPCs derived from the lateral wall of the lateral 
ventricle of the adult mouse. Expression was first normalized against β-Actin (e and f) or Myl6 (g), after which 
the relative expression to the expression in mouse ESCs was calculated. Values are mean + standard deviation 
(SD) of one representative out of 3 experiments and presented on a 10 log scale.
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and differentiation protocols. Alternatively, a confounding factor may have been transcription initiation down-
stream of Sox2 in certain cell types, which yields transcripts that encompass Sox2ot exon 6 sequences.
ESC-based neural differentiation cultures are a mixture of distinct cell types, which include ESCs, NSCs/
NPCs, and early neurons. During neural differentiation Sox2otb/c RNA levels were rather negatively correlated 
with Sox2 RNA levels (Fig. 1f) but the heterogeneic nature of the cultures thwarts to directly link Sox2otb/c 
levels to Sox2 levels. To investigate whether Sox2 levels are indeed negatively correlated with Sox2otb/c levels we 
measured the levels of Sox2 and Sox2otb/c in Sox2 heterozygous and homozygous ESC lines, in multiple mon-
oclonal ESC-derived, radial glia-like neural stem (NS) cell lines generated from wild type mouse ESCs, and in 
neurosphere cultures of primary NPCs from the lateral ventricle of the adult mouse brain. NS cells express two 
to three-fold less Sox2 RNA44,45 (Fig. 1g) but contain higher levels of Sox2otb/c RNA in comparison with mouse 
ESCs. Primary NPCs contain higher Sox2otb/c RNA levels, whereas Sox2 levels are further reduced (Fig. 1g). In 
contrast to previous studies on Sox2ot expression in immortalized transformed cells32–34, we observed a negative 
correlation between Sox2otb/c and Sox2 RNA levels (Spearman r = −0,7857, P-value = 0.048)(Supplementary 
Fig. S2h).
Transcriptional activity of Sox2ot alters Sox2 RNA levels in cis. Next we wondered whether the 
negative correlation between Sox2ot and Sox2 is caused by a direct mechanism. Long non-coding RNAs are 
known to regulate neighboring genes in a variety of ways by either a cis (only the allele from which the lncRNA 
is transcribed is affected) or trans (the effect is independent of the allele from which the lncRNA is transcribed) 
mechanism. However, knocking out all three Sox2ot genes (Sox2otb, Sox2otc, and the 545 kb upstream of Sox2 
located Sox2dot (Supplementary Fig. S1b)) simultaneously is extremely difficult. Moreover, such a strategy would 
likely perturb ordinary locus regulation as removal of critical Sox2ot promoter sequences may delete important 
regulatory sequences that are key for correct expression of neighboring genes. To circumvent these pitfalls, we 
opted to enhance the transcriptional activity of Sox2otb in Sox2 expressing cells that normally contain very low 
levels of Sox2ot. We introduced the human ubiquitin C (UbiC) promoter directly upstream of Sox2otb exon 1 
by homologous recombination in mouse Sox2eGFP ESCs (Fig. 2a,c), which have one copy of Sox2 replaced by 
eGFP22. Three clones contained an insertion of the UbiC promoter into the eGFP allele (UbiCeGFP) and two into 
the Sox2 allele (UbiCSox2) (Fig. 2d, e). Sox2otb was highly transcribed in all targeted ESCs, albeit, levels were 
lower when the UbiC promoter was inserted into the Sox2 allele, hinting towards the existence of an allele-specific 
modulatory mechanism (Fig. 2f).
If the negatively correlated expression of Sox2 and Sox2ot is an immediate consequence of Sox2ot expres-
sion, an effect on Sox2 as well as eGFP (trans regulation) or, on either Sox2 or eGFP (cis regulation) should be 
evident in the targeted cells. Indeed, Sox2ot transcription resulted in a 20–30% reduction in Sox2 or eGFP levels 
(Fig. 2g, h). However, reduced expression was solely observed for the gene (Sox2 or eGFP) that was located on 
the targeted allele. These data demonstrate that Sox2ot transcription regulates Sox2 transcription in cis. Although 
reductions were relatively moderate, a compensatory mechanism was activated in the ESCs that have decreased 
Sox2 levels as illustrated by enhanced eGFP levels. This is reminiscent of the results in hybrid ESCs, in which 
allele-specific reduction of Sox2 by deletion of the ESC prevalent transcriptional enhancer led to upregulation of 
Sox2 from the unmodified allele20.
To determine whether the Sox2 downregulation is specific for the whole population or whether only a pro-
portion of the population contributed to the lower Sox2 levels we quantified Sox2 RNA at the single cell level by 
smFISH. smFISH allows us to count the expression of individual RNA molecules in individual cells, which reveals 
expression heterogeneity within the population. We measured Sox2 levels in 700 cells of each ESC line (Fig. 2i, 
and Supplementary Fig. S3b). Only when Sox2ot was expressed from the Sox2 allele we observed a ~20% reduc-
tion in the means (77 versus 96 (Sox2eGFP) or 98 (UbiCeGFP) transcripts). Moreover, the distribution of Sox2 
gene expression in UbiCSox2 cells differed from UbiCeGFP and the parental Sox2eGFP cells (Mann-Whitney U; 
FDR = 3.19e-10 and FDR = 1.11e-10, respectively), whereas the distributions in UbiCeGFP and Sox2eGFP cells 
were comparable. This analysis confirmed that Sox2 RNA levels are decreased when Sox2ot is transcribed from 
the same allele and showed that this effect is likely not restricted to a subpopulation of cells (Fig. 2i).
Mouse ESCs overexpressing Sox2ot are very similar to wild type ESCs. Next we investigated the 
effect of Sox2ot overexpression on the maintenance and differentiation of mouse ESCs. On basis of morphology 
we could not identify phenotypic differences between the parental Sox2eGFP ESCs and the Sox2ot overexpress-
ing ESCs (Fig. 3a). The absence of a maintenance phenotype was underscored by the analysis of the expression of 
platelet endothelial cell activation marker CD31 (PECAM) and stage-specific embryonic antigen (SSEA1), which 
discriminates naïve and primed pluripotent cell states44,45. Sox2eGFP and Sox2ot overexpressing lines showed a 
similar and homogeneous CD31 expression profile, whereas SSEA1 was more heterogeneously expressed which 
is a normal feature of ESCs (Fig. 3b). Also the expression of other pluripotency genes like Nanog and Oct4 was not 
altered (Supplementary Fig. S4a, S4b). In addition, prolonged passaging at a constant splitting ratio did not reveal 
gross differences in the expansion rate between Sox2eGFP and Sox2otb overexpressing ESCs (data not shown). 
Possibly this is due to adaptation of the UbicSox2 ESCs to lower levels of Sox2 RNA by acquiring more normal 
SOX2 protein levels (Supplementary Fig. S4c). Since Sox2otb is induced during the differentiation of ESCs into 
neuroectoderm we also investigated the effect of Sox2otb overexpression on neuroectodermal differentiation. 
Using EB-based differentiation protocols we could not detect quantitative or temporal differences in the genera-
tion of either NSCs or more mature Tubb3 positive cells (Fig. 3c,d). In addition, the differentiation into mesendo-
derm as determined by Brachyury expression is largely unaltered (Supplementary Fig. S4d). Taken together these 
results indicate that enhanced Sox2ot levels do not majorly alter the phenotype of ESCs and do not exert gross 
effects on the EB-based differentiation of mouse ESCs.
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Figure 2. Allele-specific overexpression of endogenous Sox2otb. (a) Schematic view of the targeting strategy 
and targeting construct to generate allele-specific transcription of Sox2ot. R = EcoRV and S = SbfI restriction 
sites. (b) Illustration of the genetic possibilities after targeting the Sox2eGFP ESC line: Sox2eGFP (untargeted), 
UbiCeGFP (Sox2ot is expressed from the eGFP allele), or UbiCSox2 (Sox2ot is expressed from the Sox2 allele). 
(c) Southern blotting showing correctly recombined Sox2eGFP ESC clone using a 3′ probe (EcoRV restricted 
DNA). (d) and (e) Southern blot analysis showing correct targeting of the eGFP allele (UbiCeGFP) or Sox2 
(UbiCSox2) allele using eGFP (d) or Sox2 (e) specific probes (SbfI restricted DNA). Full blots are shown in 
Supplementary Fig. S3a. (f) Sox2otb expression in Sox2eGFP, UbiCeGFP, and UbiCSox2 cells as measured 
by qRT-PCR. (g) eGFP expression measured by flow cytometry in Sox2eGFP, UbiCeGFP, and UbiCSox2 
cells. (h) Sox2 RNA levels in Sox2eGFP, UbiCeGFP, and UbiCSox2 cells measured by qRT-PCR. (i) smFISH 
quantification of Sox2 RNA copies per single cell in Sox2eGFP, UbiCeGFP, and UbiCSox2 lines. The gray 
line depicts the distribution of Sox2 in Sox2eGFP cells. ***P value < 0.002, **P value < 0.01 *P value < 0.05. 
Results are from three independent experiments using (sub)clones of Sox2eGFP (n = 2), UbiCeGFP (n = 3), 
and UbiCSox2 (n = 2). Values are presented as mean +/− SD (g and h) or +SD (10 log scale (f)). qRT-PCR data 
were normalized against β-Actin, and relative levels to the levels in Sox2eGFP cells were determined. Statistical 
analysis was performed using the paired t-test, except for flow cytometry results (Wilcoxon signed-rank test) 
and smFISH results (Mann-Whitney U test).
www.nature.com/scientificreports/
6Scientific RepoRts |  (2018) 8:386  | DOI:10.1038/s41598-017-18649-4
Sox2otb/c is enriched in the nucleus but not associated to chromatin. Many lncRNAs that regulate 
transcription are enriched in the nucleus. We therefore investigated the cellular localization of Sox2ot. As our 
Sox2ot exonic smFISH probe set was not specific enough, we analyzed the cellular localization of Sox2ot RNA 
by cell fractionation and qRT-PCR. Sox2ot RNA was 4 times more enriched in the nucleus than Sox2 RNA but 
6 times less than Neat1, a lncRNA that is highly abundant in the nucleus46 (Fig. 4a). Next we examined whether 
Sox2ot is associated to the chromatin fraction. LncRNAs that function through a trans-acting mechanism are 
often found enriched in the chromatin fraction, like Neat146. In support of the observed in cis effect of Sox2otb/c 
we predominantly found Sox2ot RNA in the soluble nuclear fraction (Fig. 4b).
H3K4 methylation is unaltered in Sox2otb overexpressing mouse ESCs. The allele-specific reg-
ulation of Sox2 prompted us to investigate the nature of this regulation. A large group of cis-acting lncRNA 
transcripts represses genes by recruiting chromatin-modifying proteins that install a repressive histone mark 
such as H3K27me3 or H3K9me3, or by controlling H3K4 methylation47. To gain evidence for the existence of a 
Sox2ot dependent chromatin-modifying mechanism we compared H3K4me1, H3K4me2, H3K4me3, H3K9me3, 
and H3K27me3 chromatin marks in the region between the first exon of Sox2otb and the last exon of Sox2otb/c 
in cells expressing Sox2 and Sox2ot at different ratios, i.e. ESCs and ESC-derived NPCs, using publicly available 
H3 methylation chromatin immunoprecipitation-sequencing (ChIP-seq) data sets (Fig. 4c, and Supplementary 
Fig. S5a and d). The only histone methylation profiles that are strongly altered between ESCs and ESC-derived 
NPCs are confined to a conserved region in the proximal enhancer/promoter region of Sox2 ~4 kb downstream 
of the first exon of Sox2otc (Supplementary Fig. S5a,b, and c). In this region H3K27me3 and H3K4me3 were high 
in ESCs indicating a bivalent chromatin signature, which is linked to key developmental genes48,49. The bivalent 
histone status is lost in this region in ESC-derived NPCs. We wondered whether overexpression of Sox2otb would 
change the ESC chromatin into a more NPC-like chromatin regarding H3K4me3. We performed H3K4me3 ChIP 
Figure 3. ESCs overexpressing endogenous Sox2otb are similar to Sox2eGFP ESCs. (a) Phase contrast pictures 
of Sox2eGFP, UbiCeGFP, and UbiCSox2 cells cultured in 2i medium (100x magnification). (b) SSEA1 and CD31 
expression in Sox2eGFP, UbiCeGFP, and UbiCSox2 cells as measured by flow cytometry. (c and d) RNA levels 
of Sox1 (c) and Tubb3 (d) during EB-mediated neural differentiation of Sox2eGFP, UbiCeGFP, and UbiCSox2 
cells as measured by qRT-PCR. RNA levels were normalized against β-actin. RNA levels relative to the levels 
in Sox2eGFP cells are depicted on a 10 log scale. The results of one representative experiment (out of three 
independent experiments) using (sub)clones of Sox2eGFP (n = 2), UbiceGFP (n = 3), and UbiCSox2 (n = 2) is 
depicted as mean +/− SD.
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assays for this region but did not observe differences in H3K4me3 between the cell lines (Fig. 4d). Although we 
did not rule out the involvement of other epigenomic changes, we decided to investigate other candidate regula-
tory mechanisms.
Sox2otb transcription impairs the formation of the chromatin promoter-enhancer loop driv-
ing expression of Sox2. Development and homeostasis require coordinate regulation of neighboring genes 
through enhancers and locus control regions50. Chromatin looping enables transcription activation by juxta-
posing locus control regions (LCRs), distal regulatory elements and promoter elements, and thus, function by 
bringing transcription factors, coactivators, and RNA polymerase II together. In ESCs multiple chromatin loops 
exist in the Sox2 locus51. The most prevalent chromatin interaction is formed by the Sox2 regulatory region 1 
(SRR1) upstream of Sox2 and a 13 kb super enhancer termed Sox2 control region (SCR) located ~100 kb down-
stream of Sox220,52 (Fig. 4e). Deletion of this super enhancer decreases Sox2 levels in mouse ESCs 6 to 9 fold20,52. 
Thus, if a decrease in Sox2 levels were the consequence of Sox2otb mediated transcriptional interference the 
SRR1-SCR interaction would likely be diminished. Through chromosome conformation capture (3C) we ana-
lyzed whether the SRR1-SCR chromatin interaction was altered in Sox2otb overexpressing (UbiCeGFP) ESCs, 
which did not show altered Sox2 levels, compared to parental Sox2eGFP ESCs. We indeed observed a lower fre-
quency of SRR1-SCR interactions in Sox2otb overexpressing cells versus Sox2eGFP cells (Fig. 4f). In summary, 
transcriptional activity of Sox2otb negatively correlates with Sox2 levels, and in addition, enhanced Sox2otb tran-
scription correlates with reduced chromatin interactions between the upstream regulatory sequence of Sox2 and 
the super enhancer of Sox2 in mouse ESCs.
Discussion
Through transcription analysis in combination with genetic modification of the endogenous Sox2otb locus we 
identified that transcriptional activity of Sox2otb represses Sox2 expression in mouse ESCs. In contrast to our 
Figure 4. Sox2 locus-specific H3K4 trimethylation and chromatin interactions in ESCs overexpressing Sox2otb. 
(a) Analysis of Sox2ot RNA localization in ESCs. Sox2ot is enriched in the nucleus when compared to β-Actin 
as determined by qRT-PCR after subcellular fractionation. The ratio (+SD) of nuclear/total RNA (200ng input) 
relative to that of β-actin is depicted on a 10 log scale. Neat1 is a lncRNA that is enriched in the nucleus, and which is 
predominantly associated to chromatin46. (b) Analysis of the nuclear localization of Sox2ot in ESCs by qRT-PCR. The 
depicted ratio of chromatin bound RNA (+SD) is relative to that of β-actin. (c) Genome browser view of H3K4me3 
density signals in the regulatory Sox2 region of ESCs and ESC-derived NPCs67. For quantification of the difference see 
Supplementary Fig. 5Sa, b, and c. (d) H3K4me3 ChIP results for the region depicted between vertical lines in  
(c). Depicted H3K4me3 levels are relative to H3K4me3 levels of the housekeeping gene Myl6. (e) Schematic drawing 
of the dominant chromatin loop in ESCs formed by interaction of the Sox2 proximal region (Sox2 regulatory region 
1) (SRR1) with a P300 bound super enhancer (SCR) located ~110 kb downstream of Sox2. HindIII fragments and 
primers used are shown. (f) 3C chromatin conformation capture of the SRR1-SCR interaction depicted in (e). Values 
are relative to interactions of the Sox2 intergenic region upstream of Sox2otc. Values are represented as mean +/− SD 
from three independent experiments (n = 10). *Paired t-test P value = 0.02.
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findings, previous studies in human cancer as well as cancer cell lines have demonstrated a positive correlation 
between Sox2ot and Sox2 in certain but not all cell types investigated32–34. A quantitative and qualitative compar-
ison of the published expression data is rather difficult due to the genomic positions of the primers used as the 
applied primer pairs recognize either a variety of Sox2ot splice variants or amplify only Sox2ot sequences down-
stream of Sox2. Nevertheless, the positive co-regulation of Sox2 by Sox2ot has been strongly supported by ectopic 
overexpression or knockdown of Sox2ot pointing to a trans effect32–34. One may argue that transcription regu-
latory mechanisms of certain genes in human cells are different from those in murine cells, however, the strong 
conservation of the whole Sox2ot genomic region rather suggests a highly similar mode of operation. We believe 
that the disparities with the results obtained in this study are more likely caused by the differences in the cells ana-
lyzed, as gene regulation is very much cell type specific. In addition, cancer cells have undergone many epigenetic 
and genetic changes that interfere with the specificity and integrity of regular gene transcription programs53. Since 
we investigated early neural development using non-transformed mouse cells our data indicate that Sox2 regula-
tion during stem cell maintenance and differentiation is completely different from Sox2 regulation in cancer cells.
Cis regulation of neighboring genes has been proposed to be an important function of many lncRNA genes, 
but up to now this has only been proven for a very small subset of lncRNAs predominantly involved in imprinting 
and X inactivation because of the more easily detectable allele-specific modifications47. In general, a major hurdle 
has been selection of an allele-specific genomic modification strategy to identify allele-specific differences that 
represent a bona fide phenotype. In addition, modification of lncRNA genes to study cis-acting mechanisms is 
rather challenging. Introducing single or small mutations that alter the function or expression of uncharacterized 
lncRNAs is very complicated due to the non-coding nature of these genes. Nevertheless, insertion of a strong 
polyadenylation signal that prematurely truncates the lncRNA transcript has been successfully exploited to gain 
insight into the requirement of the full-length lncRNA27. However, premature polyadenylation strategies do not 
allow analysis of the role of lncRNA transcription initiation or that of promoter/enhancer sequences. Instead 
deletion of presumed important regulatory regions may be considered to address their role. Recent genome edit-
ing advances using CRISPR/Cas9 have facilitated the deletion of genomic sequences54 but deletion of important 
promoter or exon sequences imposes the risk of removing important transcriptional regulatory regions of the 
neighboring genes, in particular, because lncRNAs are often transcribed from enhancer and promoter proximal 
sequences of adjacent genes. This may result in false attribution of the role of the modified lncRNA. As to Sox2ot 
the existence of at least three independent transcriptional initiation sites of Sox2ot, and possibly more as indicated 
by human CAGE datasets, would make the generation of a full knockout rather unrealistic. Moreover, one of the 
Sox2ot transcription initiation sites (that of Sox2otc) is located in regulatory sequences proximal of Sox2. Deletion 
of this genomic sequence may directly alter Sox2 transcription independent of Sox2otc. As feasible alternative we 
created a promoter insertion that drives transcription of only one of the Sox2ot genes to study the role of Sox2otb 
overexpression in development and the regulation of Sox2. Using this overexpression system we demonstrate that 
the reduction in Sox2 RNA levels is caused by allele-specific transcriptional activity of Sox2otb. The reduced levels 
of Sox2 did not exert a loss of pluripotent stem cell self-renewal phenotype, as may have been expected, likely due 
to adaptation of the ESCs to decreased Sox2 RNA levels. It is known that a decrease in Sox2 levels in ESCs acti-
vates a feedback mechanism enhancing expression of Sox220. Also in the UbicSox2 cells we observed upregulation 
of the other Sox2 allele (here eGFP allele) indicating the activation of such feedback loop and the importance of 
having higher levels of Sox2. However, since the other allele is non-functional, enhanced expression of the other 
allele was ineffective. Instead the UbicSox2 cells adapted to lower Sox2 levels by regaining SOX2 to a level similar 
to that of the parental Sox2eGFP cells.
Sox2 is also crucial for neuroectodermal differentiation of ESCs, and lower Sox2 levels favor mesendoderm 
commitment9. If the SOX2 protein levels would not have been enhanced upon adaptation a differentiation phe-
notype would have been expected in the cells that overexpress Sox2otb from the Sox2 allele. Although Sox2 adap-
tation may have obscured an early neuroectodermal, Sox2-dependent differentiation defect, a Sox2-independent 
trans effect was not observed. Thus our results indicate that the main function of Sox2otb is cis regulation of Sox2 
rather than affecting cell physiology in trans via other routes. The importance of Sox2ot transcriptional activity is 
underscored by the genomic conservation of Sox2ot between mammals and fugu, which is much higher in Sox2ot 
promoter (proximal) sequences than exon sequences (Supplementary Fig. S1c).
The introduced Sox2otb transcriptional activity led to decreased Sox2 transcription and reduced interaction 
of the Sox2 proximal promoter region (SRR1) with the ESC-specific enhancer in this genomic region. However, 
we cannot rule out that other chromatin interactions are affected as well. In the presented heterozygous ESC 
model maximally 50% of a specific chromatin loop can be altered when considering an in cis effect. Therefore, 
only differences in very dominant chromatin loops, either the ones that are newly formed or the regular ones, are 
detectable. A hypothetical mechanism that would fit our observations is transcriptional repression by virtue of 
blocking recruitment of RNA polymerase II to the SSRI region (Fig. 5a). A very similar mechanism is exploited by 
Airn, which repress Igf2r by preventing RNA polymerase II recruitment to the Igf2r promoter27.
As well-balanced Sox2 protein levels are crucial for correct development of the distinct subsets of neurons in 
the neural tube10,11, it is tempting to speculate that during development the main function of Sox2ot is controlling 
Sox2 levels. In this respect the 20–30% reduction in expression of Sox2 RNA that we have observed may seem 
irrelevant. However, recently it became clear from single cell RNA sequence analysis in primary mouse cortical 
NSCs/NPCs that Sox2 dosage regulates their division rate and controls their ability to maintain an undifferenti-
ated state55. This study demonstrated that very modest decreases in Sox2 levels in NSCs/NPCs are accompanied 
by rapid increments of the neuronal specification factor Neurogenin2 (Fig. 5b). Moreover, an approximately 20% 
reduced expression of Sox2 (the same reduction as we observed in Sox2ot overexpressing ESCs) appeared to be a 
threshold for expression of the neural differentiation markers Eomes and Tbr1 (Fig. 5b). These data indicate that 
a subtle decrease of Sox2 may have a profound impact on the status of NSC/NPCs regarding their differentiation 
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potential, and that Sox2ot transcription through the Sox2 gene may render NSCs/NPCs more susceptible to neu-
ral differentiation.
We believe that the here proposed role of Sox2ot is likely conserved in numerous loci containing key differenti-
ation genes. Transcriptome data have revealed that analogous overlapping transcripts are present in the Sox1 and 
Sox4 loci. It will be interesting to learn the underlying nature of these Sox regulatory mechanisms, to what extent 
this regulation exists in the mammalian genome, and how disruptions disturb development.
Methods
Cell culture. Mouse ES cell lines (E14-cl2244, E14 subclone IB10, R1, CCE, and Sox2eGFP22 (parental mouse 
ESCs as well as the targeted clones) were cultured feeder-free or on irradiated mouse embryonic fibroblasts 
(MEFs) on 0.1% gelatinized tissue culture surface in DMEM containing 1 mM L-glutamine, 1x non-essential 
amino acids (NEAA), PenStrep 1%, 1000 U/ml human LIF (Peprotech), 50 μM β-mercaptoethanol and 15% 
mouse ESC tested fetal bovine serum (FBS) (Life Technologies). Sox2eGFP ESCs were kindly provided by the late 
Dr. L. Pevny, University of North Carolina, Chapel Hill. For ChIP, 3C, differentiation and qRT-PCR cells were first 
cultured for 4 passages in 2i medium56 (DMEM/F12/NeuralBasal, Glutamax, PenStrep 1%, human LIF 1000 U/
ml (Peprotech), 50 μM β-mercaptoethanol, 0.5x B27 plus vitamin A (ThermoFisher), 0.5x N2 (ThermoFischer), 
1 μM PD0325901 (Axon Medchem) and 3 μM CHIR99021 (Axon Medchem) and a FBS percentage that was 
gradually decreased from 15% to 1%. Cells were passaged using Trypsin/EDTA (0.05%/0.02%). Cells were main-
tained at 37 °C and 5% CO2. Prior to the experiments the quality of the cells was analyzed by flow cytometric 
analysis using anti-mouse SSEA1-BV421 (BD) and anti-mouse CD31-PerCPefluor710 (eBioscience) antibodies. 
SOX2 was measured by flow cytometry using a goat anti-Sox2 polyclonal antibody (SantaCruz, Biotechnology, 
sc-17319), in combination with an anti-goat-Alexa568 secondary antibody (Thermo Fisher Scientific). Staining 
was performed using  the fix & perm kit (Thermo Fisher Scientific) according the manufacturer’s instructions.
Targeting Sox2eGFP mouse ES cells. Two independent homologous recombination exper-
iments were performed using Sox2OTb targeting vectors containing UbiCloxPHyTKpAloxP or 
UbiClox2272PurDTKpAlox2272 selection cassettes. The selection modules were inserted 9 nucleotides upstream 
of the identified Sox2OTb transcription start site (chr 3: 34,459,297 NCBI37/mm9) into the genomic sequence 
(chr 3: 34,453,460–34,463,055 NCBI37/mm9) that was amplified from 129Ola genomic DNA using Phusion 
polymerase (NEB). The knockin constructs were introduced into Sox2eGFP ESCs by electroporation, and drug 
resistant clones were selected using hygromycin (110 μg/ml) or puromycin (1.5 μg/ml). Homologous recombi-
nants were identified by Southern blot analysis of EcoRV restricted genomic DNA using 32P labelled Sox2otb 
flanking probes. In total, 465 colonies were screened for correct homologous recombination. Five correctly 
recombined clones were further investigated to identify whether the Sox2 or eGFP allele was targeted. To this 
end SbfI restricted genomic DNA was separated by pulse field gel electroforesis (PFGE) and analyzed by Southern 
blotting using 32P labelled eGFP and Sox2 probes. Three clones contained an insertion of the UbiC promoter into 
the eGFP allele (UbiCeGFP) and two into the Sox2 allele (UbiCSox2).
Figure 5. Proposed model of transcriptional interference to modulate Sox2 levels during neural development. 
(a) Hypothetical model illustrating Sox2 and Sox2ot transcription in ESCs and NSCs/NPCs. In ESCs Sox2 
(green) is predominantly transcribed, whereas Sox2ot (red) transcription is predominantly off. In NSCs Sox2 
and Sox2ot are transcribed in the same cell. On basis of our data we propose a dynamic on/off situation. If 
Sox2ot is transcribed Sox2 transcription is repressed, and vice versa. (b) Adapted graph from a single cell RNA 
profiling study by Hagey and Muhr55 showing the influence of subtle reductions in Sox2 on the expression of 
neuronal genes. The observed 20–30% reduction in Sox2 transcription by Sox2ot transcription (indicated by 
green bars) lies at the threshold of the expression of neural genes Tbr1 and Eomes and corresponds to a steep 
rise in the expression of the proneural gene Ngn2 in cortical NSCs/NPCs.
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RNA in situ hybridization. Whole mount in situ hybridization was performed according standard proto-
cols. In short, dissected E9.25 embryos (C57Bl/6) were fixed in 4% PFA O/N. Fixed embryos were twice washed 
in PBS 0.1% Tween-20 (Sigma) (PBST), and dehydrated by subsequent methanol washing steps (25-50-75 and 
100% methanol). Dehydrated embryos were slowly rehydrated (10′ per step) at RT while rotating. After rehy-
dration the brain vesicle was punctured and the surround membrane ruptured to prevent trapping of the ribo-
probes. Embryos were treated with proteinase K (10 mg/ml) for 10′, and gently rinsed in PBST. Next embryos 
were again fixed in 4% PFA and 0.2% glutaraldehyde for 20′ while rotating, washed in PBST, and incubated in 
50% PBT/50% hybridization solution (HS) (HS: 50% formamide (Sigma), 1.3x SSC, pH 5.0 (Ambion), 5 mM 
EDTA, pH 8.0 (Ambion), 50 mg/ml yeast tRNA (Sigma), 0.2% Tween-20 (Sigma), 0.5% CHAPS (Thermo Fisher 
Scientific), and 100 mg/mL Heparin (Sigma)), and subsequently 100% HS. Riboprobes, generated by T7 polymer-
ase in vitro transcription (antisense and sense Sox2, Sox2OTb and Sox2OTb/c digoxigenin labeled RNA probes 
(sequences in Table S1)), were added to HS and incubated for 20 hours at 70 °C. Embryos were washed 3 times 
with 2x SSC, 0.1% CHAPS, three times with 0.2x SSC, 0.1% CHAPS, and twice with 1x KTBT (50 mM TrisHCl, 
pH 7.5, 150 mM NaCl, 10 mM KCl and 1% Triton X-100). Embryos were incubated with 10 ug/ml of RNase A in 
KTBT for 30 min. at 37 °C, blocked with 2% blocking solution (Roche), and 20% heat inactivated sheep serum, 
and subsequently O/N incubated with AP conjugated a-DIG, Fab fragment (Sigma) in the same blocking buffer 
at 4 °C. Embryos were 5 times washed in 0.1% Tween-20 and 1 mM levisamole (Roche) in ddH2O, and subse-
quently stained in 1x BM purple (Roche) plus 0.1% Tween, 1 mM levamisole. Reaction was stopped by washing 
in ddH2O.
Whole mount stained embryos, were embedded in 2% agarose and cross-sectioned on a vibratome (Leica). 
Mice were maintained under specific-pathogen-free conditions. All animal experiments were approved by the 
Animal Experiments Committee of the LUMC performed to the recommendations and guidelines set by the 
LUMC and by the Dutch Experiments on Animals Act that serves the implementation of guidelines on the pro-
tection of experimental animals by the Council of Europe.
RNA-linker mediated (RLM)-RACE and in vitro transcription translation. The used RLM-RACE 
procedure has been extensively described elsewhere57. Sox2ot reverse primers were located in exon 1 of Sox2otc. 
In vitro transcription/translation of human TP53 and the full-length Sox2otb and Sox2otc cDNA sequences was 
performed using TNT® Quick Coupled Transcription/Translation System (Promega) according the manufactur-
er’s protocol. 35M labeled proteins were separated on 5–15% and 20% polyacrylamide gels.
ESC differentiation. For embryoid body (EB) differentiation the original protocol was slightly adapted58. 
For neural differentiation: ESCs were seeded as a single cell suspension at a concentration of 100,000-200,000 
cells/ml in ESC media containing FBS (as in the original protocol) or knockout serum replacement (KSR)59 lack-
ing hLIF and 2i on ultra-low attachment plates (Corning). After 4 days of culture all trans retinoic acid (ATRA) 
(Sigma) or the synthetic substitute EC23 (Abcam) was added to the media at a concentration of 0.5 μM. Media 
was changed once every two days. For mesendodermal differentiation, aggregated ESCs were cultured in 2i media 
containing 3 μM CHIR99021 but without PD0325901, hLIF, and FBS as has been described for monolayer dif-
ferentiation9. 3 ½ days after addition of CHIR99021 EBs were manually dissociated using the embryoid body 
dissociation kit (Miltenyi Biotech) according the manufacturer’s instructions. Cells were stained for Oct4 and 
Brachyury using mouse anti-Oct4-BV421 (BD) and goat anti-Brachyury (SC-17745, SantaCruz) and a second-
ary donkey anti goat Alexa568 antibody (Thermo Fisher Scientific) using the fix & perm kit (Thermo Fisher 
Scientific) according the manufacturer's protocol. Oct4 and Brachyury expression was measured on a LSRII flow 
cytometer (BD).
For monolayer differentiation we adapted the protocol used by Engberg et al.60. In brief, mouse ESCs were 
seeded at a density of 15,000 cells/cm2 onto 0.1% gelatin (Sigma) coated dishes in 2i media, lacking hLIF 
and 2i, but containing 1% FBS. Media was replaced with DMEM/F12/Neuralbasal containing L-glutamine 
(ThermoFisher), PenStrep 1%, 1x N2 (ThermoFisher), and 1x B27 without vitamin A (ThermoFisher), and ATRA 
(Sigma) or EC23 (Abcam), or hBMP4 (Peprotech) at the concentrations indicated, 12 hours after seeding the cells. 
Cells were cultured for the indicated periods and media was replaced every two days. NS cell lines were generated 
from different ESC lines using N2B27 media as described elsewhere61. One of the clones has been extensively 
characterized44.
RNA isolation and quantitative PCR analysis. Total RNA was isolated directly from the cells using 
Trizol (Life technologies) or NucleoSpin® columns (Macherey-Nagel). Following DNaseI treatment (Roche), 
cDNA was generated from 100–500 ng RNA using Transcriptor reverse transcriptase (Roche) and random hex-
amers or an oligod(T) primer according the manufacturer’s protocol. After the samples had been checked for 
genomic DNA contaminations, cDNA was measured quantitatively on a Bio-Rad CFX96 using SensiFASTTM Sybr 
green PCR mix (Bioline) and the primers listed in Supplementary Table S1. All primers were tested for a com-
parable and linear amplification efficiency using a dilution series of cDNA or gDNA. RNA levels were normal-
ized against β-actin and 18 S, which yielded similar outcomes. For direct quantitative comparison of expression 
levels between ESCs and NS cells levels were normalized against housekeeping gene Myl6 because Myl6 expres-
sion is unaltered between ESCs and NSCs44. All measurements were performed in triplicate. Relative expression 
was calculated using the comparative Ct method, known as the 2–[delta][delta]Ct method, where [delta][delta]
Ct = [delta]Ct(sample) - [delta]Ct(reference). Dependent on the experiment, the reference samples were the 2i 
samples (also described as day 0 of differentiation), or the parental ESC line Sox2eGFP.
Single molecule fluorescence in situ hybridization (smFISH). Mouse ESCs were cultured in 2i 
medium or differentiated in N2B27 media without additives for 4 days as described above. Cells were detached 
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with Accutase (Gibco), resuspended in serum containing medium, and fixed by adding paraformaldehyde to 
an end-concentration of 4% and subsequent incubation for 12 minutes at RT. Fixed cells were pelleted by a 3′ 
centrifugation and subsequently resuspended in 70% ethanol. Samples were stored at 4 °C until use. smFISH of 
Sox2 (Stellaris VSMF-3075-5-BS probe set) was performed exactly as before62 and signals were quantified using 
custom MATLAB scripts. Sox2ot transcription was determined using a custom probe set covering Sox2otb intron 
2, which was designed by homemade MATLAB scripts.
Chromatin immunoprecipitation (ChIP) and 3C conformation capture. The chromatin of a single 
cell suspension of mouse ESCs was crosslinked in ESC medium containing 1% formaldehyde. Protocols used 
were previously described by Lee et al.63 (ChIP) and Stadhouders et al.64 (3C). For ChIP: the nuclear fraction was 
sonicated for 9 minutes (30″ on, 30″ off) using a Biorupter UCD-200 (Diagnode). After sonication, H3K4me3 
chromatin was precipitated overnight at 4 °C in 0.1% fraction V BSA, protease inhibitors (Roche), 16.7 mM 
trisHCl, 167 mM NaCl, 1.25 mM EDTA, 0.01% SDS, 1% Triton X-100, Dynabeads Protein G (ThermoFisher) and 
1 ug H3K4me3 rabbit polyclonal antibody (Diagenode). Chromatin was eluted in 1% SDS, and 0.1 M NaHCO3, 
de-crosslinked at 65 °C for 8–12 hours, treated with RNAse A and ProtK, and purified using phenol/chloroform 
extraction. Mouse insulin promoter primers and Myl6 primers were used as negative control and positive/nor-
malization control, respectively. For 3C: chromatin was restricted with HindIII (Fermentas) for 24 hours and O/N 
ligated at 16 °C. Chromatin was de-crosslinked at 65 °C for 8–12 hours, treated with RNAse A and ProtK, and 
purified using phenol/chloroform extraction. Quality and quantity of DNA was checked by a linear amplification 
of Sox2UTR genomic sequences. Ligation efficiencies were checked through amplification of ESC-specific Dppa2 
chromatin loop65.
Subcellular fractionation. Cell fractionation: mouse ESCs were divided into two fractions and used for 
either total RNA isolation or nuclear RNA isolation. Nuclear RNA was isolated as previously described57. In brief, 
cells were lysed and nuclei were pelleted after centrifugation (1350 g at 4 °C for 5 min). Cells (total RNA) or nuclei 
(nuclear RNA) were lysed using RA1 RNA lysis buffer (Macherey-Nagel) and RNA was isolated on NucleoSpin® 
columns (Macherey-Nagel) according to the manufacturer’s instructions. 200 ng of RNA was used in the reverse 
transcription reaction that was performed as described above.
Nuclear fractionation: Fractionation of the nucleus was performed as described by Werner et al.66 In brief, 
crude nuclei were resuspended in 250 μl NRB (20 mM HEPES pH 7.5, 50% Glycerol, 75 mM NaCl, 1 mM DTT, 
1x protease inhibitor cocktail) and centrifuged for 5′ at 500 g at 4 °C. The pellet was again resuspended in 250 μl 
NRB and 1 volume of NUN buffer ((20 mM HEPES, 300 mM NaCl, 1 M Urea, 1% NP-40 Substitute, 10 mM 
MgCl2, 1 mM DTT) was added, followed by a 5′incubation on ice after which the suspension was centrifuged 
(1,200 g, 5 min, 4 °C). The soluble fraction supernatant was transferred to a tube and the pellet was resuspended 
in 1 ml buffer A (20 mM HEPES pH 7.5, 10 mM KCl, 10% glycerol, 340 mM sucrose, 4 mM MgCl2, 1 mM DTT, 
and 1x Protease Inhibitor Cocktail (Roche) and centrifuged (1,200 g, 5 min, 4 °C). The chromatin pellet was resus-
pended in 50 μl buffer A, and 500 μl Trizol (Life technologies) was added. Trizol was added as well to the soluble 
nuclear fraction. Subsequently, RNA was extracted following the manufacturer’s guidelines. cDNA was generated 
as described above.
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